Universal Health Services Inc (UHS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $11.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Universal Health Services Inc (UHS) Earnings: Report Dates and Results
Universal Health Services (UHS) is expected to report earnings on Feb 23, 2027. In the quarter ended Sep 30, 2026, Universal Health Services reported EPS of $5.22, below the $5.31 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
UHS has an expected report date of Feb 23, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 3.7% below the $5.88 reported for the quarter ended Dec 31, 2025.
UHS Earnings Call
The latest UHS earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, UHS beat 29, missed 10 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $4.73B, up 5.1% from $4.50B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $5.22 | $5.31 | $4.35 - $5.51 | -1.69% | Miss | -8.3% | 15 | 2 up, 2 down | Oct 27, 2026 | $4.73B |
| Jun 30, 2026 | $5.98 | $5.66 | $5.54 - $7.17 | +5.65% | Beat | +11.8% | 12 | 1 up, 0 down | Jul 27, 2026 | $4.64B |
| Mar 31, 2026 | $5.62 | $5.46 | $5.12 - $6.61 | +2.93% | Beat | +16.1% | 12 | 1 up, 1 down | Apr 27, 2026 | $4.50B |
| Dec 31, 2025 | $5.88 | $5.88 | $5.63 - $6.40 | 0.00% | In line | +19.5% | 14 | 1 up, 0 down | Feb 25, 2026 | $4.49B |
| Sep 30, 2025 | $5.69 | $4.95 | $4.30 - $5.98 | +14.95% | Beat | +53.4% | 14 | 5 up, 0 down | Oct 27, 2025 | $4.50B |
| Jun 30, 2025 | $5.35 | $4.96 | $4.74 - $5.15 | +7.86% | Beat | +24.1% | 16 | 2 up, 1 down | Jul 28, 2025 | $4.28B |
| Mar 31, 2025 | $4.84 | $4.36 | $4.09 - $4.74 | +11.01% | Beat | +30.8% | 15 | 8 up, 2 down | Apr 28, 2025 | $4.10B |
| Dec 31, 2024 | $4.92 | $4.18 | $3.78 - $4.51 | +17.84% | Beat | +57.2% | 14 | 2 up, 0 down | Feb 26, 2025 | $4.11B |
| Sep 30, 2024 | $3.71 | $3.70 | $3.38 - $4.09 | +0.27% | Beat | +45.5% | 14 | 0 up, 0 down | Oct 24, 2024 | $3.96B |
| Jun 30, 2024 | $4.31 | $3.32 | $3.14 - $3.53 | +29.82% | Beat | +70.4% | 13 | 2 up, 0 down | Jul 24, 2024 | $3.91B |
| Mar 31, 2024 | $3.70 | $3.14 | $2.89 - $3.45 | +17.83% | Beat | +58.1% | 14 | 3 up, 0 down | Apr 24, 2024 | $3.84B |
| Dec 31, 2023 | $3.13 | $2.88 | $2.70 - $3.10 | +8.68% | Beat | +3.6% | 13 | 0 up, 0 down | Feb 27, 2024 | $3.70B |
| Sep 30, 2023 | $2.55 | $2.36 | $2.19 - $2.57 | +8.05% | Beat | +0.4% | 14 | 0 up, 1 down | Oct 25, 2023 | $3.56B |
| Jun 30, 2023 | $2.53 | $2.42 | $2.25 - $2.65 | +4.55% | Beat | +15.0% | 14 | 1 up, 0 down | Jul 25, 2023 | $3.55B |
| Mar 31, 2023 | $2.34 | $2.19 | $1.91 - $2.43 | +6.85% | Beat | +8.8% | 17 | 0 up, 1 down | Apr 25, 2023 | $3.47B |
| Dec 31, 2022 | $3.02 | $2.96 | $2.71 - $3.30 | +2.03% | Beat | +2.4% | 15 | 0 up, 0 down | Feb 27, 2023 | $3.45B |
| Sep 30, 2022 | $2.54 | $2.42 | $2.01 - $2.84 | +4.96% | Beat | -4.9% | 15 | 0 up, 1 down | Oct 25, 2022 | $3.34B |
| Jun 30, 2022 | $2.20 | $2.09 | $2.06 - $3.33 | +5.26% | Beat | -41.5% | 16 | 0 up, 1 down | Jul 25, 2022 | $3.32B |
| Mar 31, 2022 | $2.15 | $2.47 | $2.11 - $2.73 | -12.96% | Miss | -11.9% | 15 | 1 up, 0 down | Apr 25, 2022 | $3.29B |
| Dec 31, 2021 | $2.95 | $2.87 | $2.69 - $3.20 | +2.79% | Beat | -17.8% | 15 | N/A | Feb 24, 2022 | $3.28B |
| Sep 30, 2021 | $2.67 | $2.76 | $2.62 - $2.94 | -3.26% | Miss | -7.3% | 11 | 1 up, 0 down | Oct 25, 2021 | $3.16B |
| Jun 30, 2021 | $3.76 | $2.69 | $2.46 - $2.83 | +39.78% | Beat | +28.3% | 11 | N/A | Jul 26, 2021 | $3.20B |
| Mar 31, 2021 | $2.44 | $2.24 | $2.07 - $2.53 | +8.93% | Beat | +41.0% | 11 | N/A | Apr 26, 2021 | $3.01B |
| Dec 31, 2020 | $3.59 | $2.78 | $2.62 - $3.10 | +29.14% | Beat | +28.7% | 12 | N/A | Feb 25, 2021 | $3.09B |
| Sep 30, 2020 | $2.88 | $1.86 | $1.53 - $3.09 | +54.84% | Beat | +44.7% | 13 | N/A | Oct 29, 2020 | $2.91B |
| Jun 30, 2020 | $2.93 | $0.65 | -$0.32 - $1.77 | +350.77% | Beat | +6.2% | 13 | N/A | Jul 27, 2020 | $2.73B |
| Mar 31, 2020 | $1.73 | $2.55 | $1.98 - $2.85 | -32.16% | Miss | -29.4% | 15 | N/A | Apr 27, 2020 | $2.83B |
| Dec 31, 2019 | $2.79 | $2.57 | $2.43 - $2.68 | +8.56% | Beat | +17.7% | 15 | N/A | Feb 26, 2020 | $2.90B |
| Sep 30, 2019 | $1.99 | $2.30 | $2.18 - $2.40 | -13.48% | Miss | -10.8% | 16 | N/A | Oct 24, 2019 | $2.82B |
| Jun 30, 2019 | $2.76 | $2.50 | $2.34 - $2.60 | +10.40% | Beat | +11.7% | 17 | N/A | Jul 25, 2019 | $2.86B |
| Mar 31, 2019 | $2.45 | $2.60 | $2.42 - $2.88 | -5.77% | Miss | 0.0% | 18 | N/A | Apr 25, 2019 | $2.80B |
| Dec 31, 2018 | $2.37 | $2.34 | $2.21 - $2.48 | +1.28% | Beat | +18.5% | 19 | N/A | Feb 27, 2019 | $2.75B |
| Sep 30, 2018 | $2.23 | $2.01 | $1.86 - $2.13 | +10.95% | Beat | +49.7% | 16 | N/A | Oct 25, 2018 | $2.65B |
| Jun 30, 2018 | $2.47 | $2.40 | $2.28 - $2.48 | +2.92% | Beat | +27.3% | 15 | N/A | Jul 25, 2018 | $2.68B |
| Mar 31, 2018 | $2.45 | $2.59 | $2.43 - $2.71 | -5.41% | Miss | +16.7% | 16 | N/A | Apr 25, 2018 | $2.69B |
| Dec 31, 2017 | $2.00 | $1.84 | $1.72 - $1.94 | +8.70% | Beat | +11.1% | 16 | N/A | Feb 28, 2018 | $2.64B |
| Sep 30, 2017 | $1.49 | $1.69 | $1.58 - $1.75 | -11.83% | Miss | -6.9% | 13 | N/A | Oct 25, 2017 | $2.54B |
| Jun 30, 2017 | $1.94 | $2.06 | $2.00 - $2.15 | -5.83% | Miss | 0.0% | 12 | N/A | Jul 25, 2017 | $2.61B |
| Mar 31, 2017 | $2.10 | $2.07 | N/A | +1.45% | Beat | +6.1% | N/A | N/A | Apr 25, 2017 | $2.61B |
| Dec 31, 2016 | $1.80 | $1.81 | N/A | -0.55% | Miss | +5.3% | N/A | N/A | Feb 28, 2017 | $2.48B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $21.76, up 30.8% from the year before. It was $7.32 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $21.76 | +30.8% |
| Dec 31, 2024 | $16.64 | +57.7% |
| Dec 31, 2023 | $10.55 | +6.5% |
| Dec 31, 2022 | $9.91 | -16.2% |
| Dec 31, 2021 | $11.82 | +6.2% |
| Dec 31, 2020 | $11.13 | +11.4% |
| Dec 31, 2019 | $9.99 | +4.9% |
| Dec 31, 2018 | $9.52 | +26.4% |
| Dec 31, 2017 | $7.53 | +2.9% |
| Dec 31, 2016 | $7.32 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,500 words across 17 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,520 | 17 | |
| 2026Q2 | Jun 30, 2026 | 6,230 | 15 | |
| 2026Q1 | Mar 31, 2026 | 5,061 | 17 | |
| 2025Q4 | Dec 31, 2025 | 7,169 | 18 | |
| 2025Q3 | Sep 30, 2025 | 6,824 | 18 | |
| 2025Q2 | Jun 30, 2025 | 7,321 | 16 | |
| 2025Q1 | Mar 31, 2025 | 6,158 | 17 | |
| 2024Q4 | Dec 31, 2024 | 9,043 | 17 |
2026Q3 Earnings Call
Opening remarks
Darren Lehrich Vice President of Investor Relations Good morning, and welcome to Universal Health Services' third quarter 2026 earnings conference call. I am Darren Lehrich, Vice President of Investor Relations. With me this morning are our President and CEO, Marc Miller, and our Chief Financial Officer, Steve Filton. Marc and Steve will offer some remarks about the quarter, and then we will open up to Q&A. During today's conference call, we will be using words such as believes, expects, anticipates, estimates, and similar words that represent forecast projections and forward-looking statements. For anyone not familiar with the risks and uncertainties inherent in these forward-looking statements, we recommend a careful reading of the section on risk factors and forward-looking statements and risk factors in our Form 10-K for the year ended December 31st, 2025, and in our Form 10-Q for the quarter ended June 30, 2026. In addition, we may reference measures during today's call, such as EBITDA, adjusted EBITDA, adjusted EBITDA net of NCI, and adjusted net income attributable to UHS, which are non-GAAP financial measures. Information and reconciliations of these non-GAAP financial measures to net income attributable to UHS can be found in yesterday's press release and in our supplemental materials on our website. With that, let me now turn it over to Marc for some introductory remarks.
Marc Miller President and CEO Thank you, Darren. Good morning, and thank you for joining today's call. I will begin with our key takeaways from the quarter, performance relative to our expectations, the principal operating drivers, and progress on our strategic priorities before Steve reviews the detailed financial results and our outlook. Overall, underlying performance in the third quarter reflected sequential improvement in several areas. Acute care demand remained strong, behavioral health volumes demonstrated an increase relative to recent quarters, and labor trends continued to moderate. Expense management remained disciplined overall. Health insurance exchange trends were consistent with our expectations. Steve will provide the reported financial results and segment metrics in his remarks. Third quarter results included certain items that were not reflected in the outlook we provided with our second quarter results in July. These items included the benefit from the expansion of existing Medicaid supplemental programs in several states, partially offset by other non-recurring litigation and transaction costs, which Steve will take you through in a moment. Against that backdrop, I want to highlight three operating and strategic priorities: acute care capacity and outpatient access points, integrating Talkspace, and advancing the recertification process at Laurel Ridge Treatment Center in Texas. First, our recent investments in acute care inpatient capacity helped us meet favorable demand in our markets. The additional 177 beds added during the second quarter are expected to continue ramping through year-end.
Frequently Asked Questions About UHS
When is Universal Health Services's next earnings date?
Universal Health Services's next earnings report is expected for Feb 23, 2027.
Did UHS beat earnings estimates last quarter?
No. Universal Health Services reported EPS of $5.22 for the quarter ended Sep 30, 2026, below the $5.31 estimate by 1.69%.
What EPS do analysts expect from UHS next quarter?
The consensus EPS estimate for Universal Health Services for the quarter ending Dec 31, 2026 is $5.66 from 19 analysts, with estimates from $4.80 to $6.17.
How often does UHS beat earnings estimates?
Universal Health Services beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +7.32%.
UHS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors